DRAD Digirad Corporation

POWAY, Calif., May 29 /PRNewswire/ -- Digirad Corporation (NASDAQ:DRAD), a leading provider of cardiovascular imaging services and solid-state nuclear medicine imaging products, announced it has selected Allen & Caron, Inc., headquartered in Irvine, Calif., with offices in New York and London, as its agency for investor relations and corporate communications. Digirad designed and commercialized the first solid-state nuclear camera for the detection of cardiovascular disease and other medical conditions and now manufactures and markets a range of imaging products and services for nuclear and ultrasound applications in cardiology, internal medicine and general imaging. Digirad is addressing the rising demand for imaging services and products by independent physicians, larger multi-specialty practices, hospitals and clinics. Chief Financial Officer Todd Clyde remarked: "As we grow our in-office cardiovascular imaging services, add to our solid-state nuclear products line, and drive towards sustainable profitability, we are also looking for increased visibility in the investment community, financial markets and media. We chose Allen & Caron because of its solid reputation within those circles and history of success in building investment support and enhancing valuation. Allen & Caron President and Chief Operating Officer Rene Caron commented: "Digirad's first-quarter shows solid results in key performance metrics. With a sound business plan, experienced senior management, strong balance sheet and substantial liquidity, we feel Digirad will succeed and offers a compelling investment opportunity." About Digirad Corporation Digirad Corporation provides diagnostic imaging products and services to physician offices, hospitals and other medical providers for use in cardiology, internal medicine, and general imaging applications. Digirad designed and commercialized the first solid-state nuclear gamma camera for the detection of cardiovascular disease and other medical conditions. The unique lightweight and compact design of Digirad's cameras also allows use in small office spaces and for mobile services. For more information, go to http://www.digirad.com/. Digirad(R) is a registered trademark of Digirad Corporation. About Allen & Caron Allen & Caron is a full-service corporate, investor and marketing communications agency serving the needs of public companies. The Allen & Caron international client base includes emerging growth companies in a range of industry segments. The firm has offices in Irvine, California; New York City and London; maintains a presence in Paris; and has an affiliate relationship with a leading investor relations firm in Italy, which has offices in Milan and Rome. Forward-Looking Statements Digirad cautions that statements included in this press release that are not a description of historical facts are forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historical or current facts and use words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" and other words and terms of similar meaning in connection with a discussion of future operating or financial performance or events. Examples of such statements include the statements regarding our expectations that we will grow our in-office cardiovascular imaging services, add to our solid-state nuclear products line, improve operational efficiencies, obtain sustainable profitability, increase visibility in the financial markets and follow a sound business plan. The inclusion of these and other forward-looking statements should not be regarded as a representation by Digirad that any of its plans will be achieved. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in Digirad's business including, without limitation: the degree to which Digirad's camera systems and related services will be accepted by physicians and hospitals, some of whom may experience reliability issues or technical problems; the ability of Digirad effectively to market, sell and distribute its medical devices, and related services given its limited capabilities in these areas; Digirad's ability to manage risks relating to product liability, warranty claims, recalls, property damage and personal injury with respect to its imaging systems; and other risks detailed in Digirad's Securities and Exchange Commission filings, including its Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission. Given these uncertainties, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Digirad undertakes no obligation to revise or update this press release including the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Contact: Allen & Caron Digirad Corporation Dan Matsui (investors) Todd Clyde Len Hall (media) Chief Financial Officer 949 474 4300 858 726 1600 DATASOURCE: Allen & Caron CONTACT: investors, Dan Matsui, or media, Len Hall, both of Allen & Caron, +1-949-474-4300; or Todd Clyde, Chief Financial Officer of Digirad Corporation, +1-858-726-1600 Web site: http://www.allencaron.com/ http://www.digirad.com/ Company News On-Call: http://www.prnewswire.com/comp/133897.html

Copyright